ATORVASTATINE ALTER 40 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400941730221
  • CIP7 4173022
  • CIS 63974084

What the source publishes

Holder
LABORATOIRES ALTER
Active ingredients
ATORVASTATINE, ATORVASTATINE CALCIQUE TRIHYDRATÉE
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2011-05-23
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400941730221
{
  "cis": "63974084",
  "cip7": "4173022",
  "form": "comprimé pelliculé",
  "name": "ATORVASTATINE ALTER 40 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)",
  "cip13": "3400941730221",
  "holder": "LABORATOIRES ALTER",
  "routes": [
    "orale"
  ],
  "holders": [
    "LABORATOIRES ALTER"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "4.94",
  "authorisedOn": "2011-05-23",
  "compositions": [
    {
      "name": "ATORVASTATINE",
      "nature": "FT",
      "strength": "40 mg",
      "linkageNumber": "1",
      "substanceCode": "19809",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
      "nature": "SA",
      "strength": "43,38 mg",
      "linkageNumber": "1",
      "substanceCode": "92464",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.92",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ATORVASTATINE ALTER 40 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2022-11-18",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATORVASTATINE",
    "ATORVASTATINE CALCIQUE TRIHYDRATÉE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400941730221"